Looking for advice on my mom’s hair loss – what actually works for women? 1/23/2026
Minoxidil and spironolactone are recommended for female hair loss, and they can be used together. A dermatologist visit is advised to confirm the type of hair loss and rule out other issues.
View this post in the Community →
Similar Community Posts Join
6 / 6 resultscommunity I’m crashing out (female pattern hair loss)
A woman experiencing female pattern hair loss has been using topical minoxidil and ketoconazole shampoo but is seeking further treatment options due to plateaued results. Suggestions include spironolactone, finasteride, dutasteride, and other treatments like PRP, while emphasizing the importance of consulting a dermatologist and conducting thorough medical evaluations.
community Low iron and hair loss connection
A 39-year-old woman noticed hair thinning and found she has an iron deficiency, which may be linked to hair loss. Suggestions included seeing a dermatologist, using spironolactone, and minoxidil.
community Can I take bicalutamide for hair loss as a man, but don’t want to transition?
A 23-year-old man with hair loss, despite using dutasteride, oral minoxidil, and RU58841, is considering bicalutamide for regrowth but is concerned about feminization. Alternatives like topical estrogen, JXL069, and spironolactone are discussed, with suggestions to explore thyroid levels and other potential underlying conditions.
community for anyone who is on the fence about oral minoxidil should read this NYT article it might help. it's an old one but people might need a refresher. https://www.nytimes.com/2022/08/18/health/minoxidil-hair-loss-pills.html
Oral minoxidil is more effective than topical for hair regrowth but may cause unwanted body hair growth and cardiovascular side effects. Some users experience positive results, while others discontinue use due to side effects like chest pain.
community Conversations about hair-loss with normies: They're always funny.
Hair loss is often misunderstood by those not affected, leading to frustration for those who research treatments like Minoxidil, finasteride, and hair transplants. Many people offer well-meaning but uninformed advice, while those knowledgeable about hair loss focus on proven treatments.
community Dont stop using Minoxidil i beg you! Dont be fool like me.
Stopping minoxidil causes significant hair loss, as continued use is necessary for maintaining gains. Combining minoxidil with finasteride may help maintain hair, but both treatments are typically lifelong commitments.
Related Research
6 / 6 resultsresearch Hair Sciences: An interview with Dr. Rodney Sinclair on female pattern hair loss
This article involves an interview with dermatologist Rodney Sinclair and provides no new research findings.
research Common Dermatologic Conditions
This review discusses common skin conditions in primary care settings and provides guidance on differential diagnoses and selecting appropriate topical treatments, but it reports no new clinical results.
research Primary Care of Adult Women
This article reviews common dermatologic conditions seen in primary care, such as acne and skin cancer, but reports no new findings.
research ANÁLISE DA ABORDAGEM DERMATOLÓGICA DA ALOPECIA ANDROGENÉTICA FEMININA ATRAVÉS DO USO DE MINOXIDIL
This study concluded that 5% topical Minoxidil remains a first-line treatment for female androgenetic alopecia by increasing hair density and thickness, while low-dose oral Minoxidil and combination therapies may also be effective.
research The state‐of‐the‐art in the management of androgenetic alopecia: A review of new therapies and treatment algorithms
This abstract outlines a guide reviewing both FDA-approved and off-label therapies for androgenetic alopecia and proposes treatment algorithms based on scientific research, highlighting a gap in common treatments for this prevalent condition.
research Understanding and Addressing Hair Disorders in Transgender Individuals
This article provides a framework for understanding hair disorders and treatment options in transgender individuals undergoing hormonal therapy and reports no new clinical results.